- Home
- SMXT vs ICCC Comparison
SMXT vs ICCC Comparison
Compare SMXT & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMXT
- ICCC
- Stock Information
- Founded
- SMXT 2008
- ICCC 1982
- Country
- SMXT United States
- ICCC United States
- Employees
- SMXT N/A
- ICCC N/A
- Industry
- SMXT
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- SMXT
- ICCC Health Care
- Exchange
- SMXT NYSE
- ICCC Nasdaq
- Market Cap
- SMXT 58.9M
- ICCC 48.3M
- IPO Year
- SMXT 2024
- ICCC 1987
- Fundamental
- Price
- SMXT $1.13
- ICCC $5.07
- Analyst Decision
- SMXT
- ICCC
- Analyst Count
- SMXT 0
- ICCC 0
- Target Price
- SMXT N/A
- ICCC N/A
- AVG Volume (30 Days)
- SMXT 96.5K
- ICCC 27.6K
- Earning Date
- SMXT 05-19-2025
- ICCC 05-14-2025
- Dividend Yield
- SMXT N/A
- ICCC N/A
- EPS Growth
- SMXT N/A
- ICCC N/A
- EPS
- SMXT N/A
- ICCC N/A
- Revenue
- SMXT $22,986,881.00
- ICCC $26,493,169.00
- Revenue This Year
- SMXT N/A
- ICCC N/A
- Revenue Next Year
- SMXT N/A
- ICCC N/A
- P/E Ratio
- SMXT N/A
- ICCC N/A
- Revenue Growth
- SMXT N/A
- ICCC 51.63
- 52 Week Low
- SMXT $0.60
- ICCC $3.34
- 52 Week High
- SMXT $13.48
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- SMXT N/A
- ICCC 42.10
- Support Level
- SMXT N/A
- ICCC $5.01
- Resistance Level
- SMXT N/A
- ICCC $5.72
- Average True Range (ATR)
- SMXT 0.00
- ICCC 0.18
- MACD
- SMXT 0.00
- ICCC -0.05
- Stochastic Oscillator
- SMXT 0.00
- ICCC 14.96
About SMXT SOLARMAX TECHNOLOGY INC
SolarMax Technology Inc is an integrated solar and renewable energy company. It operates in two segments namely the United States and China. The United States business includes the sale and installation of photovoltaic and battery backup systems. China operations consist of operating and maintaining solar farm projects and identifying and procuring solar farm projects for resale to third parties. Some of its products are LG Solar Panels, QCELL Solar Panels, Panasonic Solar Panels, and others. The company generates a majority of its revenue from the Solar energy systems.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.